On June 28th, Gelunhui reported that Chengda Pharmaceutical (301201.SZ) announced that the 5th Board of Directors and the 5th Supervisory Board meetings were held on June 28th, 2024, and approved the proposal to extend the implementation period of some raised funds investment projects. It was agreed to adjust the implementation period of the raised funds investment projects for "pharmaceutical intermediate projects" and "active pharmaceutical ingredient projects" to December 31, 2024.
诚达药业(301201.SZ)：拟将“医药中间体项目”“原料药项目”延期至2024年12月31日
Chengda Pharmaceutical (301201.SZ): Plans to postpone the "Pharmaceutical intermediate project" and "Active pharmaceutical ingredient project" until December 31, 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated